OPPENHEIMER & CO INC - PIERIS PHARMACEUTICALS INC ownership

PIERIS PHARMACEUTICALS INC's ticker is PIRS and the CUSIP is 720795103. A total of 85 filers reported holding PIERIS PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
OPPENHEIMER & CO INC ownership history of PIERIS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$1,738
-83.0%
10,5000.0%0.00%
Q1 2023$10,248
-6.2%
10,5000.0%0.00%
Q4 2022$10,920
-9.0%
10,5000.0%0.00%
Q3 2022$12,000
-40.0%
10,5000.0%0.00%
Q2 2022$20,000
-37.5%
10,5000.0%0.00%
-100.0%
Q1 2022$32,000
-31.9%
10,500
-13.9%
0.00%0.0%
Q2 2021$47,000
-4.1%
12,200
-35.8%
0.00%0.0%
Q1 2021$49,000
+2.1%
19,0000.0%0.00%0.0%
Q4 2020$48,000
-4.0%
19,000
-20.8%
0.00%0.0%
Q3 2020$50,000
-35.1%
24,000
-3.2%
0.00%
-50.0%
Q2 2020$77,000
+14.9%
24,800
-16.5%
0.00%0.0%
Q1 2020$67,000
-24.7%
29,700
+20.2%
0.00%0.0%
Q4 2019$89,000
+287.0%
24,700
+49.7%
0.00%
+100.0%
Q4 2016$23,000
-14.8%
16,500
+10.0%
0.00%0.0%
Q3 2016$27,000
+12.5%
15,0000.0%0.00%0.0%
Q2 2016$24,000
-78.8%
15,000
-74.9%
0.00%
-66.7%
Q1 2016$113,000
+232.4%
59,680
+297.9%
0.00%
+200.0%
Q4 2015$34,000
+88.9%
15,000
+50.0%
0.00%0.0%
Q3 2015$18,00010,0000.00%
Other shareholders
PIERIS PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
Lynx1 Capital Management LP 1,136,319$3,443,0003.20%
Aquilo Capital Management, LLC 3,708,882$11,238,0001.65%
Soleus Capital Management, L.P. 4,134,868$12,529,0001.62%
GREAT POINT PARTNERS LLC 2,199,076$6,663,0001.61%
BVF INC/IL 5,328,239$16,145,0000.65%
Cutter & CO Brokerage, Inc. 406,229$1,231,0000.37%
WEALTH EFFECTS LLC 80,400$244,0000.11%
PLATINUM INVESTMENT MANAGEMENT LTD 1,028,322$3,116,0000.10%
Rhenman & Partners Asset Management AB 300,000$909,0000.09%
Woodline Partners LP 1,587,475$4,810,0000.08%
View complete list of PIERIS PHARMACEUTICALS INC shareholders